{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:31:37Z","timestamp":1767832297224,"version":"3.49.0"},"reference-count":222,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004769","name":"University of Pavia","doi-asserted-by":"publisher","award":["FRG2021"],"award-info":[{"award-number":["FRG2021"]}],"id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Human aging, a natural process characterized by structural and physiological changes, leads to alterations of homeostatic mechanisms, decline of biological functions, and subsequently, the organism becomes vulnerable to external stress or damage. In fact, the elderly population is prone to develop diseases due to deterioration of physiological and biological systems. With aging, the production of reactive oxygen species (ROS) increases, and this causes lipid, protein, and DNA damage, leading to cellular dysfunction and altered cellular processes. Indeed, oxidative stress plays a key role in the pathogenesis of several chronic disorders, including hepatic diseases, such as non-alcoholic fatty liver disease (NAFLD). NAFLD, the most common liver disorder in the Western world, is characterized by intrahepatic lipid accumulation; is highly prevalent in the aging population; and is closely associated with obesity, insulin resistance, hypertension, and dyslipidemia. Among the risk factors involved in the pathogenesis of NAFLD, the dysbiotic gut microbiota plays an essential role, leading to low-grade chronic inflammation, oxidative stress, and production of various toxic metabolites. The intestinal microbiota is a dynamic ecosystem of microbes involved in the maintenance of physiological homeostasis; the alteration of its composition and function, during aging, is implicated in different liver diseases. Therefore, gut microbiota restoration might be a complementary approach for treating NAFLD. The administration of probiotics, which can relieve oxidative stress and elicit several anti-aging properties, could be a strategy to modify the composition and restore a healthy gut microbiota. Indeed, probiotics could represent a valid supplement to prevent and\/or help treating some diseases, such as NAFLD, thus improving the already available pharmacological intervention. Moreover, in aging, intervention of prebiotics and fecal microbiota transplantation, as well as probiotics, will provide novel therapeutic approaches. However, the relevant research is limited, and several scientific research works need to be done in the near future to confirm their efficacy.<\/jats:p>","DOI":"10.3390\/cells11182827","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T20:52:25Z","timestamp":1663015945000},"page":"2827","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention"],"prefix":"10.3390","volume":"11","author":[{"given":"Lucrezia Irene Maria","family":"Campagnoli","sequence":"first","affiliation":[{"name":"Department of Drug Sciences, Pharmacology Section, University of Pavia, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-1420","authenticated-orcid":false,"given":"Nicoletta","family":"Marchesi","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences, Pharmacology Section, University of Pavia, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-6127","authenticated-orcid":false,"given":"Mariapia","family":"Vairetti","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Molecular Pharmacology and Toxicology, Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7182-4272","authenticated-orcid":false,"given":"Alessia","family":"Pascale","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences, Pharmacology Section, University of Pavia, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2337-2897","authenticated-orcid":false,"given":"Andrea","family":"Ferrigno","sequence":"additional","affiliation":[{"name":"Unit of Cellular and Molecular Pharmacology and Toxicology, Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-0084","authenticated-orcid":false,"given":"Annalisa","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences, Pharmacology Section, University of Pavia, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut Microbiome and Health: Mechanistic Insights","volume":"71","author":"Tilg","year":"2022","journal-title":"Gut"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/gmic.19320","article-title":"The Role of Gut Microbiota in Immune Homeostasis and Autoimmunity","volume":"3","author":"Wu","year":"2012","journal-title":"Gut Microbes"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"625913","DOI":"10.3389\/fcimb.2021.625913","article-title":"Role and Mechanism of Gut Microbiota in Human Disease","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1183\/09031936.00134014","article-title":"Ageing and the Border between Health and Disease","volume":"44","author":"MacNee","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.3389\/fimmu.2018.02795","article-title":"Macrophages in the Aging Liver and Age-Related Liver Disease","volume":"9","author":"Stahl","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.30834","article-title":"The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis","volume":"71","author":"Papatheodoridi","year":"2020","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1617805","article-title":"Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"2020","author":"Gonzalez","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fmed.2020.00361","article-title":"Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD","volume":"7","author":"Jiang","year":"2020","journal-title":"Front. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hrncir, T., Hrncirova, L., Kverka, M., Hromadka, R., Machova, V., Trckova, E., Kostovcikova, K., Kralickova, P., Krejsek, J., and Tlaskalova-Hogenova, H. (2021). Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Microorganisms, 9.","DOI":"10.3390\/microorganisms9050957"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00284-022-02783-y","article-title":"Probiotics and Their Metabolites Reduce Oxidative Stress in Middle-Aged Mice","volume":"79","author":"Lin","year":"2022","journal-title":"Curr. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Di Pasqua, L.G., Cagna, M., Berardo, C., Vairetti, M., and Ferrigno, A. (2022). Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010194"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Berardo, C., Di Pasqua, L.G., Cagna, M., Richelmi, P., Vairetti, M., and Ferrigno, A. (2020). Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249646"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: Implications of a Premature Change in Terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCG.0000000000000666","article-title":"The Association between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in the United States Population","volume":"51","author":"Jinjuvadia","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The Global Epidemiology of NAFLD and NASH in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.4081\/ejh.2020.3175","article-title":"The Selective Blockade of Metabotropic Glutamate Receptor-5 Attenuates Fat Accumulation in an In Vitro Model of Benign Steatosis","volume":"64","author":"Ferrigno","year":"2020","journal-title":"Eur. J. Histochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1046\/j.1440-1746.17.s3.31.x","article-title":"Non-Alcoholic Steatohepatitis: Definitions and Pathogenesis","volume":"17","author":"Day","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal Models of Nonalcoholic Fatty Liver Disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte Dysfunctions Linking Obesity to Insulin Resistance and Type 2 Diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2016.12.022","article-title":"Hepatic Lipid Metabolism and Non-Alcoholic Fatty Liver Disease in Aging","volume":"455","author":"Gong","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2337\/db11-1300","article-title":"The Critical Role of Metabolic Pathways in Aging","volume":"61","author":"Barzilai","year":"2012","journal-title":"Diabetes"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de Novo Fatty Acid Synthesis to Hepatic Steatosis and Insulin Resistance: Lessons from Genetically Engineered Mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional Control of Hepatic Lipid Metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/DMSO.S182406","article-title":"Leptin Resistance: Underlying Mechanisms and Diagnosis","volume":"12","author":"Gruzdeva","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"749050","DOI":"10.3389\/fendo.2021.749050","article-title":"The Leptin System and Diet: A Mini Review of the Current Evidence","volume":"12","author":"Florio","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0802142","article-title":"Leptin: A Review of Its Peripheral Actions and Interactions","volume":"26","author":"Margetic","year":"2002","journal-title":"Int. J. Obes."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/beem.2002.0223","article-title":"Peripheral Metabolic Actions of Leptin","volume":"16","author":"Muoio","year":"2002","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cld.2009.07.009","article-title":"Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis","volume":"13","author":"Cusi","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","article-title":"Review Article: Is Non-Alcoholic Fatty Liver Disease a Spectrum, or Are Steatosis and Non-Alcoholic Steatohepatitis Distinct Conditions?","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"114933","DOI":"10.1016\/j.bcp.2022.114933","article-title":"Targeting Lipophagy as a Potential Therapeutic Strategy for Nonalcoholic Fatty Liver Disease","volume":"197","author":"Li","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fphys.2020.00850","article-title":"Lipophagy Impairment Is Associated with Disease Progression in NAFLD","volume":"11","author":"Carotti","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"601627","DOI":"10.3389\/fendo.2020.601627","article-title":"The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease","volume":"11","author":"Grefhorst","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"165765","DOI":"10.1016\/j.bbadis.2020.165765","article-title":"Gut Microbiota and Aging-A Focus on Centenarians","volume":"1866","author":"Corina","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-016-0307-y","article-title":"The Healthy Human Microbiome","volume":"8","author":"Huttenhower","year":"2016","journal-title":"Genome Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ju\u00e1rez-Fern\u00e1ndez, M., Porras, D., Garc\u00eda-Mediavilla, M.V., Rom\u00e1n-Sag\u00fcillo, S., Gonz\u00e1lez-Gallego, J., Nistal, E., and S\u00e1nchez-Campos, S. (2020). Aging, Gut Microbiota and Metabolic Diseases: Management through Physical Exercise and Nutritional Interventions. Nutrients, 13.","DOI":"10.3390\/nu13010016"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Marciano, F., and Vajro, P. (2017). Oxidative Stress and Gut Microbiota. Gastrointestinal Tissue, Elsevier.","DOI":"10.1016\/B978-0-12-805377-5.00008-4"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23129","DOI":"10.1038\/srep23129","article-title":"Human Gut Colonisation May Be Initiated in Utero by Distinct Microbial Communities in the Placenta and Amniotic Fluid","volume":"6","author":"Collado","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-018-1703-4","article-title":"The Role of the Microbiome for Human Health: From Basic Science to Clinical Applications","volume":"57","author":"Mohajeri","year":"2018","journal-title":"Eur J. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.1000097107","article-title":"Composition, Variability, and Temporal Stability of the Intestinal Microbiota of the Elderly","volume":"108","author":"Claesson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, Stability and Resilience of the Human Gut Microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00018-017-2674-y","article-title":"Gut Microbiota Changes in the Extreme Decades of Human Life: A Focus on Centenarians","volume":"75","author":"Santoro","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chakraborti, S., Chakraborti, T., Chattopadhyay, D., and Shaha, C. (2019). Role of Gut Microbiota in Combating Oxidative Stress. Oxidative Stress in Microbial Diseases, Springer.","DOI":"10.1007\/978-981-13-8763-0"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12938\/bmfh.18-032","article-title":"The Role of Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Pathways of Mechanisms","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/092986712799828283","article-title":"Reactive Oxygen Production Induced by the Gut Microbiota: Pharmacotherapeutic Implications","volume":"19","author":"Jones","year":"2012","journal-title":"CMC"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.chom.2011.09.003","article-title":"Human-Associated Microbial Signatures: Examining Their Predictive Value","volume":"10","author":"Knights","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"151500","DOI":"10.1016\/j.ijmm.2021.151500","article-title":"Microbiota Profiling in Aging-Associated Inflammation and Liver Degeneration","volume":"311","author":"Baumann","year":"2021","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Sharma, R. (2022). Emerging Interrelationship Between the Gut Microbiome and Cellular Senescence in the Context of Aging and Disease: Perspectives and Therapeutic Opportunities. Probiotics Antimicro. Prot.","DOI":"10.1007\/s12602-021-09903-3"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.arcmed.2017.11.005","article-title":"Microbiota and Aging. A Review and Commentary","volume":"48","author":"Friedland","year":"2017","journal-title":"Arch. Med. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1159\/000490615","article-title":"The Gut Microbiota and Healthy Aging: A Mini-Review","volume":"64","author":"Kim","year":"2018","journal-title":"Gerontology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7150\/ijbs.56214","article-title":"Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates","volume":"17","author":"Khan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"110310","DOI":"10.1016\/j.biopha.2020.110310","article-title":"The Influence of Probiotics on Bile Acids in Diseases and Aging","volume":"128","author":"Sivamaruthi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Salazar, N., Arboleya, S., Vald\u00c3\u00a9s, L., Stanton, C., Ross, P., Ruiz, L., Gueimonde, M., and de los Reyes-Gavil\u00c3\u00a1n, C.G. (2014). The Human Intestinal Microbiome at Extreme Ages of Life. Dietary Intervention as a Way to Counteract Alterations. Front. Genet., 5.","DOI":"10.3389\/fgene.2014.00406"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2020.10.056","article-title":"Chronic Liver Diseases and the Microbiome\u2014Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease","volume":"160","author":"Acharya","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/CIA.S295524","article-title":"NAFLD in the Elderly","volume":"16","author":"Alqahtani","year":"2021","journal-title":"CIA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1017\/S0007114509338842","article-title":"Ageing and Vitamin D Deficiency: Effects on Calcium Homeostasis and Considerations for Vitamin D Supplementation","volume":"101","author":"Oudshoorn","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Riaz Rajoka, M.S., Thirumdas, R., Mehwish, H.M., Umair, M., Khurshid, M., Hayat, H.F., Phimolsiripol, Y., Pallar\u00e9s, N., Mart\u00ed-Quijal, F.J., and Barba, F.J. (2021). Role of Food Antioxidants in Modulating Gut Microbial Communities: Novel Understandings in Intestinal Oxidative Stress Damage and Their Impact on Host Health. Antioxidants, 10.","DOI":"10.3390\/antiox10101563"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive Impact of Non-Antibiotic Drugs on Human Gut Bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"104856","DOI":"10.1016\/j.phrs.2020.104856","article-title":"Targeting the Microbiota in Pharmacology of Psychiatric Disorders","volume":"157","author":"Pascale","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1941285","article-title":"The Good, the Bad, and the Ugly of ROS: New Insights on Aging and Aging-Related Diseases from Eukaryotic and Prokaryotic Model Organisms","volume":"2018","author":"Santos","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fphar.2018.01162","article-title":"Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Conti, V., Izzo, V., Corbi, G., Russomanno, G., Manzo, V., De Lise, F., Di Donato, A., and Filippelli, A. (2016). Antioxidant Supplementation in the Treatment of Aging-Associated Diseases. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00024"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"595371","DOI":"10.3389\/fmed.2021.595371","article-title":"Oxidative Stress in Non-Alcoholic Fatty Liver Disease. An Updated Mini Review","volume":"8","author":"Marciano","year":"2021","journal-title":"Front. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","article-title":"The Gut-Brain Axis: Is Intestinal Inflammation a Silent Driver of Parkinson\u2019s Disease Pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"npj Parkinson\u2019s Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"eaaw3159","DOI":"10.1126\/scisignal.aaw3159","article-title":"Host Mitochondria Influence Gut Microbiome Diversity: A Role for ROS","volume":"12","author":"Yardeni","year":"2019","journal-title":"Sci. Signal."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tim.2016.09.011","article-title":"Rethinking Diet to Aid Human\u2013Microbe Symbiosis","volume":"25","author":"Derrien","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","article-title":"Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Gupta, H., Min, B.-H., Ganesan, R., Gebru, Y.A., Sharma, S.P., Park, E., Won, S.-M., Jeong, J.-J., Lee, S.-B., and Cha, M.-G. (2022). Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030550"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut Microbiota and Human NAFLD: Disentangling Microbial Signatures from Metabolic Disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The Gut Microbiota as an Environmental Factor That Regulates Fat Storage","volume":"101","author":"Ding","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"From the Cover: Mechanisms Underlying the Resistance to Diet-Induced Obesity in Germ-Free Mice","volume":"104","author":"Manchester","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00394-018-1748-4","article-title":"Lack of Liver Steatosis in Germ-Free Mice Following Hypercaloric Diets","volume":"58","author":"Basic","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2020.11.010","article-title":"Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease","volume":"33","author":"Sharpton","year":"2021","journal-title":"Cell Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal Microbiota Determines Development of Non-Alcoholic Fatty Liver Disease in Mice","volume":"62","author":"Llopis","year":"2013","journal-title":"Gut"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Chiu, C.C., Ching, Y.H., Li, Y.P., Liu, J.Y., Huang, Y.T., Huang, Y.W., Yang, S.S., Huang, W.C., and Chuang, H.L. (2017). Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. Nutrients, 9.","DOI":"10.3390\/nu9111220"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Porras, D., Nistal, E., Mart\u00ednez-Fl\u00f3rez, S., Olcoz, J.L., Jover, R., Jorquera, F., Gonz\u00e1lez-Gallego, J., Garc\u00eda-Mediavilla, M.V., and S\u00e1nchez-Campos, S. (2019). Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice. Mol. Nutr. Food Res., 63.","DOI":"10.1002\/mnfr.201800930"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Schneider, K.M., Bieghs, V., Heymann, F., Hu, W., Dreymueller, D., Liao, L., Frissen, M., Ludwig, A., Gassler, N., and Pabst, O. (2015). CX3CR1 Is a Gatekeeper for Intestinal Barrier Integrity in Mice: Limiting Steatohepatitis by Maintaining Intestinal Homeostasis. Hepatology.","DOI":"10.1016\/S0168-8278(15)30084-2"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Palladini, G., Di Pasqua, L.G., Berardo, C., Siciliano, V., Richelmi, P., Perlini, S., Ferrigno, A., and Vairetti, M. (2019). Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress. Can. J. Gastroenterol. Hepatol., 2019.","DOI":"10.1155\/2019\/5413461"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ye, J.Z., Li, Y.T., Wu, W.R., Shi, D., Fang, D.Q., Yang, L.Y., Bian, X.Y., Wu, J.J., Wang, Q., and Jiang, X.W. (2018). Dynamic Alterations in the Gut Microbiota and Metabolome during the Development of Methionine-Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis. World J. Gastroenterol.","DOI":"10.3748\/wjg.v24.i23.2468"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Schneider, K.M., Mohs, A., Kilic, K., Candels, L.S., Elfers, C., Bennek, E., Ben Schneider, L., Heymann, F., Gassler, N., and Penders, J. (2019). Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis. Int. J. Mol. Sci.","DOI":"10.3390\/ijms20020308"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Velayudham, A., Dolganiuc, A., Ellis, M., Petrasek, J., Kodys, K., Mandrekar, P., and Szabo, G. (2009). VSL#3 Probiotic Treatment Attenuates Fibrosis without Changes in Steatohepatitis in a Diet-Induced Nonalcoholic Steatohepatitis Model in Mice. Hepatology.","DOI":"10.1002\/hep.22711"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Krenkel, O., Puengel, T., Govaere, O., Abdallah, A.T., Mossanen, J.C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., and Hellerbrand, C. (2018). Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis. Hepatology.","DOI":"10.1002\/hep.29544"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MOG.0b013e32835ff948","article-title":"Linking Intestinal Homeostasis and Liver Disease","volume":"29","author":"Schnabl","year":"2013","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., Kau, A.L., Eisenbarth, S.C., and Jurczak, M.J. (2012). Inflammasome-Mediated Dysbiosis Regulates Progression of NAFLD and Obesity. Nature.","DOI":"10.1038\/nature10809"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Gil-G\u00f3mez, A., Brescia, P., Rescigno, M., and Romero-G\u00f3mez, M. (2021). Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: The Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers. Semin. Liver Dis.","DOI":"10.1055\/s-0041-1723752"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","article-title":"Prolonged High-Fat-Diet Feeding Promotes Non-Alcoholic Fatty Liver Disease and Alters Gut Microbiota in Mice","volume":"11","author":"Enos","year":"2019","journal-title":"World J. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Zorita, S., Aguirre, L., Milton-Laskibar, I., Fern\u00e1ndez-Quintela, A., Trepiana, J., Kajarabille, N., Mosqueda-Sol\u00eds, A., Gonz\u00e1lez, M., and Portillo, M.P. (2019). Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding\u2014A Review of Rodent Models. Nutrients, 11.","DOI":"10.3390\/nu11092156"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An Obesity-Associated Gut Microbiome with Increased Capacity for Energy Harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection between Endogenous Alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut Microbiota Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int. HBPD INT"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.31417","article-title":"Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population-Based Study of 1,355 Adults","volume":"73","author":"Alferink","year":"2021","journal-title":"Hepatology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-Omics-Based Approach","volume":"65","author":"Nobili","year":"2017","journal-title":"Hepatology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut Microbiome-Based Metagenomic Signature for Non-Invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"ref_99","first-page":"1","article-title":"Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-Alcoholic Fatty Liver Disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans with Nonalcoholic Fatty Liver Disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The Severity of Nonalcoholic Fatty Liver Disease Is Associated with Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/MCG.0b013e318269fdd5","article-title":"FAO\/WHO Guidelines on Probiotics: 10 Years Later","volume":"46","author":"Morelli","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/0255-0857.53201","article-title":"PROBIOTICS","volume":"27","author":"Gupta","year":"2009","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Kumar, H., and Salminen, S. (2016). Probiotics. Encyclopedia of Food and Health, Elsevier.","DOI":"10.1016\/B978-0-12-384947-2.00570-5"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15226\/2475-4714\/2\/3\/00127","article-title":"Probiotics as Therapeutics","volume":"2","author":"Aeron","year":"2017","journal-title":"JARB"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4161\/gmic.1.3.11712","article-title":"Probiotics-Host Communication: Modulation of Signaling Pathways in the Intestine","volume":"1","author":"Thomas","year":"2010","journal-title":"Gut Microbes"},{"key":"ref_107","first-page":"1","article-title":"Probiotic Species in the Modulation of Gut Microbiota: An Overview","volume":"2018","author":"Azad","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.maturitas.2013.02.004","article-title":"Probiotics and Prebiotics and Health in Ageing Populations","volume":"75","author":"Duncan","year":"2013","journal-title":"Maturitas"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/CMR.16.4.658-672.2003","article-title":"Potential Uses of Probiotics in Clinical Practice","volume":"16","author":"Reid","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Sanklecha, M., Verma, L., Pai, U., Mishra, S., Maqsood, S., and Birla, A. (2022). Lactobacillus Rhamnosus GG Evaluation in Acute Diarrhea (LEAD): An Observational Study. Cureus.","DOI":"10.7759\/cureus.24594"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3168\/jds.S0022-0302(05)72714-4","article-title":"Clinical Effects of Lactobacillus Acidophilus Strain L-92 on Perennial Allergic Rhinitis: A Double-Blind, Placebo-Controlled Study","volume":"88","author":"Ishida","year":"2005","journal-title":"J. Dairy Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0016-5085(89)91613-2","article-title":"Prevention of Antibiotic-Associated Diarrhea by Saccharomyces Boulardii: A Prospective Study","volume":"96","author":"Surawicz","year":"1989","journal-title":"Gastroenterology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3892\/ijmm.2012.1010","article-title":"Oral Administration of Enterococcus Faecalis FK-23 Suppresses Th17 Cell Development and Attenuates Allergic Airway Responses in Mice","volume":"30","author":"Zhang","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cea.12489","article-title":"Children with Atopic Dermatitis Show Clinical Improvement after Lactobacillus Exposure","volume":"45","author":"Wang","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1111\/j.1399-3038.2009.00958.x","article-title":"Effect of Probiotic Mix (Bifidobacterium Bifidum, Bifidobacterium Lactis, Lactobacillus Acidophilus) in the Primary Prevention of Eczema: A Double-Blind, Randomized, Placebo-Controlled Trial","volume":"21","author":"Kim","year":"2010","journal-title":"Pediatric Allergy Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3389\/fmicb.2020.00718","article-title":"Saccharomyces Cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections","volume":"11","author":"Gaziano","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/LGT.0b013e31829156ec","article-title":"Effects of Probiotics on the Recurrence of Bacterial Vaginosis: A Review","volume":"18","author":"Homayouni","year":"2014","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12937-021-00703-7","article-title":"Effect of Probiotic Supplementation along with Calorie Restriction on Metabolic Endotoxemia, and Inflammation Markers in Coronary Artery Disease Patients: A Double Blind Placebo Controlled Randomized Clinical Trial","volume":"20","author":"Moludi","year":"2021","journal-title":"Nutr. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"746585","DOI":"10.3389\/fimmu.2021.746585","article-title":"Lactobacillus Plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2016.07.001","article-title":"Lactobacillus Rhamnosus Induced Epithelial Cell Apoptosis, Ameliorates Inflammation and Prevents Colon Cancer Development in an Animal Model","volume":"83","author":"Gamallat","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1007\/s10620-016-4238-7","article-title":"Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer","volume":"61","author":"Kuugbee","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2036.2003.01638.x","article-title":"Inhibitory Effect of Probiotic Escherichia Coli Strain Nissle 1917 on Adhesion to and Invasion of Intestinal Epithelial Cells by Adherent-Invasive, E. Coli Strains Isolated from Patients with Crohn\u2019s Disease: INHIBITORY EFFECT OF PROBIOTIC E. COLI NISSLE 1917 ON AIEC COLONIZATION","volume":"18","author":"Boudeau","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1756283X11428502","article-title":"Efficacy and Safety of the Probiotic Saccharomyces Boulardii for the Prevention and Therapy of Gastrointestinal Disorders","volume":"5","author":"Kelesidis","year":"2012","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1039\/C9FO01062A","article-title":"Lactobacillus Acidophilus Alleviates Type 2 Diabetes by Regulating Hepatic Glucose, Lipid Metabolism and Gut Microbiota in Mice","volume":"10","author":"Yan","year":"2019","journal-title":"Food Funct."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1039\/D1FO00504A","article-title":"Protective Effect of Bifidobacterium Bifidum FSDJN7O5 and Bifidobacterium Breve FHNFQ23M3 on Diarrhea Caused by Enterotoxigenic Escherichia Coli","volume":"12","author":"Yang","year":"2021","journal-title":"Food Funct."},{"key":"ref_126","first-page":"17","article-title":"Influence of Lactobacillus F19 on Intestinal Microflora in Children and Elderly Persons and Impact on Helicobacter Pylori Infections","volume":"14","author":"Sullivan","year":"2002","journal-title":"Microb. Ecol. Health Dis."},{"key":"ref_127","first-page":"67","article-title":"One-Year Application of Probiotic Strain Enterococcus Faecium M-74 Decreases Serum Cholesterol Levels","volume":"106","author":"Hlivak","year":"2005","journal-title":"Bratisl Lek Listy"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12937-016-0172-y","article-title":"The Effects of the DDS-1 Strain of Lactobacillus on Symptomatic Relief for Lactose Intolerance - a Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial","volume":"15","author":"Pakdaman","year":"2015","journal-title":"Nutr. J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/MEG.0b013e3282efa40e","article-title":"The Effect of Probiotics on Gut Flora, Level of Endotoxin and Child\u2013Pugh Score in Cirrhotic Patients: Results of a Double-Blind Randomized Study","volume":"19","author":"Lata","year":"2007","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","article-title":"Probiotics Prevent Hepatic Encephalopathy in Patients with Cirrhosis: A Randomized Controlled Trial","volume":"12","author":"Lunia","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1039\/C8FO00100F","article-title":"Bifidobacteria Attenuate the Development of Metabolic Disorders, with Inter- and Intra-Species Differences","volume":"9","author":"Zhu","year":"2018","journal-title":"Food Funct."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"790046","DOI":"10.3389\/fendo.2021.790046","article-title":"Efficacy and Safety of Lactobacillus Plantarum K50 on Lipids in Koreans with Obesity: A Randomized, Double-Blind Controlled Clinical Trial","volume":"12","author":"Sohn","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/680363","article-title":"Probiotic Lactobacillus Rhamnosus GR-1 and Lactobacillus Reuteri RC-14 May Help Downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (P70) in the Neurogenic Bladder of Spinal Cord Injured Patient with Urinary Tract Infections: A Two-Case Study","volume":"2009","author":"Anukam","year":"2009","journal-title":"Adv. Urol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"23","DOI":"10.22159\/ijap.2018v10i5.28249","article-title":"A review on anti-aging properties of probiotics","volume":"10","author":"Sivamaruthi","year":"2018","journal-title":"Int. J. App. Pharm."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/19490976.2016.1256525","article-title":"Nutrition and the Gut Microbiome in the Elderly","volume":"8","author":"Salazar","year":"2017","journal-title":"Gut Microbes"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11357-008-9081-0","article-title":"Probiotics Modulate the Bifidobacterium Microbiota of Elderly Nursing Home Residents","volume":"31","author":"Lahtinen","year":"2009","journal-title":"AGE"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12603-012-0372-x","article-title":"A Probiotics-Containing Biscuit Modulates the Intestinal Microbiota in the Elderly","volume":"17","author":"Rampelli","year":"2013","journal-title":"J. Nutr. Health Aging"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clnu.2014.09.023","article-title":"Impact of Personalized Diet and Probiotic Supplementation on Inflammation, Nutritional Parameters and Intestinal Microbiota\u2014The \u201cRISTOMED Project\u201d: Randomized Controlled Trial in Healthy Older People","volume":"34","author":"Valentini","year":"2015","journal-title":"Clin. Nutr."},{"key":"ref_139","first-page":"26","article-title":"Impact of Consumption of Different Levels of Bifidobacterium Lactis HN019 on the Intestinal Microflora of Elderly Human Subjects","volume":"11","author":"Ahmed","year":"2007","journal-title":"J. Nutr. Health Aging"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"8063647","DOI":"10.1155\/2018\/8063647","article-title":"Immunomodulatory Effects of Probiotics on Cytokine Profiles","volume":"2018","author":"Azad","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"175628482097120","DOI":"10.1177\/1756284820971201","article-title":"Lactobacillus Acidophilus LB: A Useful Pharmabiotic for the Treatment of Digestive Disorders","volume":"13","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1600240","DOI":"10.1002\/mnfr.201600240","article-title":"Probiotics, Gut Microbiota, and Their Influence on Host Health and Disease","volume":"61","author":"Delgado","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of Probiotics on Gut Microbiota: Mechanisms of Intestinal Immunomodulation and Neuromodulation","volume":"6","author":"Hemarajata","year":"2013","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Chen, L., Li, H., Li, J., Chen, Y., and Yang, Y. (2019). Lactobacillus Rhamnosus GG Treatment Improves Intestinal Permeability and Modulates Microbiota Dysbiosis in an Experimental Model of Sepsis. Int. J. Mol. Med.","DOI":"10.3892\/ijmm.2019.4050"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.alcohol.2008.12.009","article-title":"Lactobacillus GG Treatment Ameliorates Alcohol-Induced Intestinal Oxidative Stress, Gut Leakiness, and Liver Injury in a Rat Model of Alcoholic Steatohepatitis","volume":"43","author":"Forsyth","year":"2009","journal-title":"Alcohol"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"C1018","DOI":"10.1152\/ajpcell.00131.2005","article-title":"Soluble Factors from Lactobacillus GG Activate MAPKs and Induce Cytoprotective Heat Shock Proteins in Intestinal Epithelial Cells","volume":"290","author":"Tao","year":"2006","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jmf.2017.3990","article-title":"Lactobacillus Acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development","volume":"21","author":"Park","year":"2018","journal-title":"J. Med. Food"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Vemuri, R., Shinde, T., Gundamaraju, R., Gondalia, S., Karpe, A., Beale, D., Martoni, C., and Eri, R. (2018). Lactobacillus Acidophilus DDS-1 Modulates the Gut Microbiota and Improves Metabolic Profiles in Aging Mice. Nutrients, 10.","DOI":"10.3390\/nu10091255"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"104103","DOI":"10.1016\/j.jff.2020.104103","article-title":"Lactobacillus Plantarum Prevents Obesity via Modulation of Gut Microbiota and Metabolites in High-Fat Feeding Mice","volume":"73","author":"Li","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/ecco-jcc\/jjx002.241","article-title":"P115 Escherichia Coli Nissle 1917 Modulate Gut Microbiota Composition in Ulcerative Colitis Patients","volume":"11","author":"Graziani","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1128\/IAI.01563-06","article-title":"Induction of Human \u03b2-Defensin 2 by the Probiotic Escherichia Coli Nissle 1917 Is Mediated through Flagellin","volume":"75","author":"Schlee","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e01011","DOI":"10.1128\/mBio.01011-14","article-title":"Saccharomyces Boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic Db\/Db Mice","volume":"5","author":"Everard","year":"2014","journal-title":"mBio"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of Ethanol-Induced Akkermansia Muciniphila Depletion Ameliorates Alcoholic Liver Disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","article-title":"Next-Generation Probiotics: The Spectrum from Probiotics to Live Biotherapeutics","volume":"2","author":"Marchesi","year":"2017","journal-title":"Nat. Microbiol"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.eng.2020.01.017","article-title":"An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease","volume":"7","author":"Yao","year":"2021","journal-title":"Engineering"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like Receptors in Alcoholic Liver Disease, Non-Alcoholic Steatohepatitis and Carcinogenesis: The Role of TLR in ALD, NASH and HCC","volume":"28","author":"Roh","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_157","first-page":"101","article-title":"Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease","volume":"57","author":"Wang","year":"2018","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/apt.13376","article-title":"Systematic review: Microbial dysbiosis and nonalcoholic fatty liver disease","volume":"42","author":"Wieland","year":"2015","journal-title":"Aliment. Pharm."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Mantovani, A., and Dalbeni, A. (2021). Treatments for NAFLD: State of Art. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052350"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of Gut Microbiota and Oxidative Stress in the Progression of Non-Alcoholic Fatty Liver Disease to Hepatocarcinoma: Current and Innovative Therapeutic Approaches","volume":"15","author":"Borrelli","year":"2018","journal-title":"Redox Biol."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Perumpail, B., Li, A., John, N., Sallam, S., Shah, N., Kwong, W., Cholankeril, G., Kim, D., and Ahmed, A. (2019). The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases, 7.","DOI":"10.3390\/diseases7010027"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1631\/jzus.B1400342","article-title":"Effect of Dietary Supplementation of Bacillus Subtilis B10 on Biochemical and Molecular Parameters in the Serum and Liver of High-Fat Diet-Induced Obese Mice","volume":"16","author":"Lei","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31401-2","article-title":"Probiotics: A Possible Role in Treatment of Adult and Pediatric Non Alcoholic Fatty Liver Disease","volume":"12","author":"Vajro","year":"2013","journal-title":"Ann. Hepatol"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1039\/C4FO00549J","article-title":"Lactobacillus Plantarum NCU116 Improves Liver Function, Oxidative Stress and Lipid Metabolism in Rats with High Fat Diet Induced Non-Alcoholic Fatty Liver Disease","volume":"5","author":"Li","year":"2014","journal-title":"Food Funct."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1007\/s00253-019-09703-4","article-title":"Lactobacillus Plantarum NA136 Improves the Non-Alcoholic Fatty Liver Disease by Modulating the AMPK\/Nrf2 Pathway","volume":"103","author":"Zhao","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1007\/s00253-014-5752-1","article-title":"Preventing Non-Alcoholic Fatty Liver Disease through Lactobacillus Johnsonii BS15 by Attenuating Inflammation and Mitochondrial Injury and Improving Gut Environment in Obese Mice","volume":"98","author":"Xin","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Ritze, Y., B\u00e1rdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., and Bischoff, S.C. (2014). Lactobacillus Rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0080169"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/469059","article-title":"Dietary Blueberry and Bifidobacteria Attenuate Nonalcoholic Fatty Liver Disease in Rats by Affecting SIRT1-Mediated Signaling Pathway","volume":"2014","author":"Ren","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3164\/jcbn.11-38","article-title":"Supplementation with Probiotics Modifies Gut Flora and Attenuates Liver Fat Accumulation in Rat Nonalcoh.holic Fatty Liver Disease Model","volume":"50","author":"Xu","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s13167-017-0117-3","article-title":"Comparative Study of Probiotic Effects of Lactobacillus and Bifidobacteria Strains on Cholesterol Levels, Liver Morphology and the Gut Microbiota in Obese Mice","volume":"8","author":"Bubnov","year":"2017","journal-title":"EPMA J."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"45176","DOI":"10.1038\/srep45176","article-title":"Probiotics May Delay the Progression of Nonalcoholic Fatty Liver Disease by Restoring the Gut Microbiota Structure and Improving Intestinal Endotoxemia","volume":"7","author":"Xue","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1007\/s10620-013-2879-3","article-title":"Clostridium Butyricum MIYAIRI 588 Improves High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats","volume":"58","author":"Seo","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2008.05.025","article-title":"Probiotics Improve High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance by Increasing Hepatic NKT Cells","volume":"49","author":"Ma","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and Antibodies to TNF Inhibit Inflammatory Activity and Improve Nonalcoholic Fatty Liver Disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/ismej.2017.24","article-title":"Faecalibacterium Prausnitzii Treatment Improves Hepatic Health and Reduces Adipose Tissue Inflammation in High-Fat Fed Mice","volume":"11","author":"Munukka","year":"2017","journal-title":"ISME J."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","article-title":"Randomized, Double-Blind, Placebo-Controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/nqy358","article-title":"Yogurt Improves Insulin Resistance and Liver Fat in Obese Women with Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Randomized Controlled Trial","volume":"109","author":"Chen","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","article-title":"Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial","volume":"35","author":"Sepideh","year":"2016","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_179","first-page":"1090","article-title":"Effect of a Probiotic on Liver Aminotransferases in Nonalcoholic Fatty Liver Disease Patients: A Double Blind Randomized Clinical Trial","volume":"15","author":"Aller","year":"2011","journal-title":"Eur. Rev. Med. Pharm. Sci"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"846873","DOI":"10.3389\/fnut.2022.846873","article-title":"Probiotic Therapy with VSL#3\u00ae in Patients with NAFLD: A Randomized Clinical Trial","volume":"9","author":"Derosa","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_181","first-page":"531","article-title":"Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-Alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial","volume":"4","author":"Shavakhi","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A Multi-Strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase Levels in NAFLD Patients: Evidence from a Randomized Clinical Trial","volume":"27","author":"Kobyliak","year":"2018","journal-title":"JGLD"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Mei, L., Tang, Y., Li, M., Yang, P., Liu, Z., Yuan, J., and Zheng, P. (2015). Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia Obtusifolia, L. Ameliorate Non-Alcoholic Fatty Liver. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138078"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Park, E.-J., Lee, Y.-S., Kim, S.M., Park, G.-S., Lee, Y.H., Jeong, D.Y., Kang, J., and Lee, H.-J. (2020). Beneficial Effects of Lactobacillus Plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat\/High Fructose Diet-Fed Rats. Nutrients, 12.","DOI":"10.3390\/nu12020542"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13568-020-01038-y","article-title":"Probiotic Bifidobacterium Lactis V9 Attenuates Hepatic Steatosis and Inflammation in Rats with Non-Alcoholic Fatty Liver Disease","volume":"10","author":"Yan","year":"2020","journal-title":"AMB Expr."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.3168\/jds.2014-8500","article-title":"Effects of Probiotic Yogurt Consumption on Metabolic Factors in Individuals with Nonalcoholic Fatty Liver Disease","volume":"97","author":"Nabavi","year":"2014","journal-title":"J. Dairy Sci."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e000315","DOI":"10.1136\/bmjgast-2019-000315","article-title":"High Potency Multistrain Probiotic Improves Liver Histology in Non-Alcoholic Fatty Liver Disease (NAFLD): A Randomised, Double-Blind, Proof of Concept Study","volume":"6","author":"Duseja","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Ma, J., Zhou, Q., and Li, H. (2017). Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients, 9.","DOI":"10.20944\/preprints201709.0040.v2"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Fianchi, F., Liguori, A., Gasbarrini, A., Grieco, A., and Miele, L. (2021). Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut\u2013Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126485"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics","volume":"125","author":"Gibson","year":"1995","journal-title":"J. Nutr."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/19490976.2017.1290756","article-title":"Dietary Fiber and Prebiotics and the Gastrointestinal Microbiota","volume":"8","author":"Holscher","year":"2017","journal-title":"Gut Microbes"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/10_2008_097","article-title":"Probiotics, Prebiotics, and Synbiotics","volume":"111","author":"Stahl","year":"2008","journal-title":"Food Biotechnology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/gutjnl-2019-318424","article-title":"Dietary Supplementation with Inulin-Propionate Ester or Inulin Improves Insulin Sensitivity in Adults with Overweight and Obesity with Distinct Effects on the Gut Microbiota, Plasma Metabolome and Systemic Inflammatory Responses: A Randomised Cross-over Trial","volume":"68","author":"Chambers","year":"2019","journal-title":"Gut"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1038\/s41598-019-41837-3","article-title":"A Prospective Randomized, Double-Blind, Placebo-Controlled, Dose-Response Relationship Study to Investigate Efficacy of Fructo-Oligosaccharides (FOS) on Human Gut Microflora","volume":"9","author":"Tandon","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"11789","DOI":"10.1038\/s41598-017-10722-2","article-title":"Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in Healthy Young Population","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1478-3231.2011.02730.x","article-title":"The Potential Role of Prebiotic Fibre for Treatment and Management of Non-Alcoholic Fatty Liver Disease and Associated Obesity and Insulin Resistance","volume":"32","author":"Parnell","year":"2012","journal-title":"Liver Int."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.ejcn.1602127","article-title":"Effects of Oligofructose on Glucose and Lipid Metabolism in Patients with Nonalcoholic Steatohepatitis: Results of a Pilot Study","volume":"59","author":"Daubioul","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.3748\/wjg.v11.i32.5053","article-title":"Effect of Lactulose on Establishment of a Rat Non-Alcoholic Steatohepatitis Model","volume":"11","author":"Fan","year":"2005","journal-title":"WJG"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Matsumoto, K., Ichimura, M., Tsuneyama, K., Moritoki, Y., Tsunashima, H., Omagari, K., Hara, M., Yasuda, I., Miyakawa, H., and Kikuchi, K. (2017). Fructo-Oligosaccharides and Intestinal Barrier Function in a Methionine\u2013Choline-Deficient Mouse Model of Nonalcoholic Steatohepatitis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175406"},{"key":"ref_200","unstructured":"Ebrahimi-Mameghani, M., Aliashrafi, S., Javadzadeh, Y., and AsghariJafarabadi, M. (2014). The Effect of Chlorella Vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease. Health Promot. Perspect."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Javadi, L., Ghavami, M., Khoshbaten, M., Safaiyan, A., Barzegari, A., and Pourghassem Gargari, B. (2017). The Effect of Probiotic and\/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial. Iran. Red Crescent. Med. J., 19.","DOI":"10.5812\/ircmj.46017"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1017\/S0007114515001889","article-title":"Influence of Galacto-Oligosaccharide Mixture (B-GOS) on Gut Micro.obiota, Immune Parameters and Metabonomics in Elderly Persons","volume":"114","author":"Vulevic","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3945\/ajcn.2008.26242","article-title":"Modulation of the Fecal Microflora Profile and Immune Function by a Novel Trans-Galactooligosaccharide Mixture (B-GOS) in Healthy Elderly Volunteers","volume":"88","author":"Vulevic","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1017\/S0007114511004697","article-title":"A Randomised Crossover Study Investigating the Effects of Galacto-Oligosaccharides on the Faecal Microbiota in Men and Women over 50 Years of Age","volume":"107","author":"Walton","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Markowiak, P., and \u015ali\u017cewska, K. (2017). Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients, 9.","DOI":"10.3390\/nu9091021"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","article-title":"Bifidobacterium Longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis","volume":"57","author":"Malaguarnera","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1017\/S0007114517000204","article-title":"Synbiotic Supplementation in Lean Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Randomised, Double-Blind, Placebo-Controlled, Clinical Trial","volume":"117","author":"Mofidi","year":"2017","journal-title":"Br. J. Nutr."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients with Nonalcoholic Fatty Liver Disease","volume":"158","author":"Scorletti","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Ferolla, S., Couto, C., Costa-Silva, L., Armiliato, G., Pereira, C., Martins, F., Ferrari, M., Vilela, E., Torres, H., and Cunha, A. (2016). Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients, 8.","DOI":"10.3390\/nu8070397"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Asgharian, A., Mohammadi, V., Gholi, Z., Esmaillzade, A., Feizi, A., and Askari, G. (2017). The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial Study. Iran. Red Crescent. Med. J., 19.","DOI":"10.5812\/ircmj.42902"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/2008-7802.178533","article-title":"The Effect of Symbiotic Supplementation on Liver Enzymes, c-Reactive Protein and Ultrasound Findings in Patients with Non-Alcoholic Fatty Liver Disease: A Clinical Trial","volume":"7","author":"Asgharian","year":"2016","journal-title":"Int. J. Prev. Med."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11357-011-9294-5","article-title":"Gut Microbiota of Healthy Elderly NSAID Users Is Selectively Modified with the Administration of Lactobacillus Acidophilus NCFM and Lactitol","volume":"34","author":"Ouwehand","year":"2012","journal-title":"AGE"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/apt.12453","article-title":"Synbiotic Consumption Changes the Metabolism and Composition of the Gut Microbiota in Older People and Modifies Inflammatory Processes: A Randomised, Double-Blind, Placebo-Controlled Crossover Study","volume":"38","author":"Macfarlane","year":"2013","journal-title":"Aliment. Pharm."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/426027","article-title":"Microbiological Effects of Consuming a Synbiotic Containing Bifidobacterium Bifidum, Bifidobacterium Lactis, and Oligofructose in Elderly Persons, Determined by Real-Time Polymerase Chain Reaction and Counting of Viable Bacteria","volume":"40","author":"Bartosch","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Ju\u00e1rez-Fern\u00e1ndez, M., Porras, D., Petrov, P., Rom\u00e1n-Sag\u00fcillo, S., Garc\u00eda-Mediavilla, M.V., Soluyanova, P., Mart\u00ednez-Fl\u00f3rez, S., Gonz\u00e1lez-Gallego, J., Nistal, E., and Jover, R. (2021). The Synbiotic Combination of Akkermansia Muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation. Antioxidants, 10.","DOI":"10.3390\/antiox10122001"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2019.009","article-title":"Fecal Microbiota Transplantation: An Update on Clinical Practice","volume":"52","author":"Kim","year":"2019","journal-title":"Clin. Endosc."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"196.2","DOI":"10.1136\/gutjnl-2017-314049","article-title":"Faecal Microbiota Transplantation in Clinical Practice","volume":"67","author":"Cammarota","year":"2018","journal-title":"Gut"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total Fecal Microbiota Transplantation Alleviates High-Fat Diet-Induced Steatohepatitis in Mice via Beneficial Regulation of Gut Microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a Healthy Intestinal Microbiota Normalizes Portal Hypertension in a Rat Model of Nonalcoholic Steatohepatitis: Liver Failure\/Cirrhosis\/Portal Hypertension","volume":"67","author":"Raurell","year":"2018","journal-title":"Hepatology"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals with Steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic Fecal Microbiota Transplantation in Patients with Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am. J. Gastroenterol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/18\/2827\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:28:54Z","timestamp":1760142534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/18\/2827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,10]]},"references-count":222,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["cells11182827"],"URL":"https:\/\/doi.org\/10.3390\/cells11182827","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,10]]}}}